Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

DUBLIN, Ireland, December 20 /PRNewswire/ --

- PopCap.com Helps Reduce Holiday Stress

As if offering up family-friendly, stress-busting games wasn't enough, PopCap Games are going further to help beat Christmas stress by giving customers 50% off all games at http://www.popcap.com until January 3rd 2008. (i)

PopCap joined forces with the Stress Management Society (UK) in 2007 to prove their games' stress relieving properties. Neil Shah, Director, The Stress Management Society (http://www.stress.org.uk) says: "A study conducted by The Stress Management Society showed that playing puzzle games like a PopCap Game for as little as 5 minutes a day has stress relieving benefits."

COPENHAGEN, Denmark, December 20 /PRNewswire/ --

- Summary: Genmab's Partner, Roche has Initiated a Phase II study of R1507 for the Treatment of Sarcoma

Genmab A/S (OMX: GEN) announced today that its partner, Roche has initiated a Phase II clinical study of R1507 for the treatment of recurrent or refractory sarcoma. The R1507 antibody was created by Genmab under the company's agreement with Roche and initiation of the trial will trigger a milestone payment to Genmab of USD 500,000.

"R1507 will be the first antibody created by Genmab under our agreement with Roche to enter Phase II development," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. "We believe that R1507 may offer an additional treatment option to sarcoma patients."

GAITHERSBURG, Maryland, December 20 /PRNewswire/ --

- Company also Establishes New Site Leadership Team at Cambridge Facility

Continuing the solidification of its role as the global biologics unit for AstraZeneca plc (AZ), MedImmune today announced that Andrew D. Skibo has joined the company as senior vice president, engineering and JoAnn Suzich, Ph.D., a 19-year veteran of the company, has been promoted to vice president, research and development, infectious disease. In addition, MedImmune announced that it has established a new site leadership team at its Cambridge facilities as a part of the plan to integrate the former Cambridge Antibody Technology (CAT) organization into AZ's new global biologics unit, functioning under the name MedImmune.

SAN MATEO, California, December 20 /PRNewswire/ --

- With Photo

- NetSuite CEO Zach Nelson Rings Opening Bell at New York Stock Exchange

NetSuite Inc. (NYSE: N), today announced the initial public offering of 6,200,000 shares of its common stock at a price of US$26.00 per share. Its CEO Zach Nelson rang the opening bell at the New York Stock Exchange.

(Photo: http://www.newscom.com/cgi-bin/prnh/20071220/AQTH078) (Logo: http://www.newscom.com/cgi-bin/prnh/20021024/SFTH024LOGO)

GREENSBORO, North Carolina, December 20 /PRNewswire/ --

PARIS, December 20 /PRNewswire/ -- iDOO.com is one of the first European portals to offer OpenID, a new service allowing any web surfer to use a single Internet address. The site's web server, http://www.openidoo.com, is available in Beta version.

Among the main developments in frequent surfing habits, one of the more laborious aspects is the daily connection to Internet sites. Users are waiting for improvements: simpler, faster connection without the risk of making mistakes or forgetting multiple user names and/or passwords.

A new service that helps web surfers identify themselves on the web. The principle is simple: